Literature DB >> 12548386

Interstitial deletion of chromosome 9, int del(9)(9q22.31-q31.2), including the genes causing multiple basal cell nevus syndrome and Robinow/brachydactyly 1 syndrome.

Carla Olivieri1, Paola Maraschio, Desiree Caselli, Carla Martini, Giampiero Beluffi, Emanuela Maserati, Cesare Danesino.   

Abstract

We report a child with a de novo interstitial deletion, 46,XY, int del(9)(9q22.31-q31.2). Cytogenetic and molecular analysis defined the boundaries of the lost region, of paternal origin, from D9S1796 to D9S938. The clinical picture included macrocephaly, frontal bossing, bilateral epicanthus, down-slanted palpebral fissures, low-set ears, hypoplastic nostrils, micrognathia, scoliosis, right single palmar crease, small nails, slender fingers, bilaterally flexed 5th finger, delayed bone age, abnormal metacarpophalangeal pattern (MCPP) profile and sole pits. No major malformation was recorded. The deleted region includes, among others, the PTCH and ROR2 genes. Mutations of the former cause the nevoid basal cell carcinoma syndrome (NBCCS) while mutations in the ROR2 gene have been found both in Robinow syndrome and in brachydactyly type 1B (BDB1). As the patient shows some clinical manifestation of both syndromes, we conclude that phenotypic changes related to haploinsufficiency of PTCH and ROR2 are recognisable in our patient even at a young age and in the presence of the more complex phenotype due to the deletion's large size. Thus the efforts to identify the genes included in a deletion are worthy as they may result in better care of the patient as, in this case, monitoring the possible development of tumours associated with NBCCS.

Entities:  

Mesh:

Year:  2002        PMID: 12548386     DOI: 10.1007/s00431-002-1116-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

Review 1.  Analysis of structural and numerical chromosome abnormalities in sperm of normal men and carriers of constitutional chromosome aberrations. A review.

Authors:  M Guttenbach; W Engel; M Schmid
Journal:  Hum Genet       Date:  1997-07       Impact factor: 4.132

2.  Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2.

Authors:  A R Afzal; A Rajab; C D Fenske; M Oldridge; N Elanko; E Ternes-Pereira; B Tüysüz; V A Murday; M A Patton; A O Wilkie; S Jeffery
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

3.  Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome.

Authors:  H van Bokhoven; J Celli; H Kayserili; E van Beusekom; S Balci; W Brussel; F Skovby; B Kerr; E F Percin; N Akarsu; H G Brunner
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

4.  Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation.

Authors:  S Takeuchi; K Takeda; I Oishi; M Nomi; M Ikeya; K Itoh; S Tamura; T Ueda; T Hatta; H Otani; T Terashima; S Takada; H Yamamura; S Akira; Y Minami
Journal:  Genes Cells       Date:  2000-01       Impact factor: 1.891

5.  Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia.

Authors:  C Olivieri; E Mira; G Delù; F Pagella; A Zambelli; L Malvezzi; E Buscarini; C Danesino
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

6.  Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B.

Authors:  M Oldridge; A M Fortuna; M Maringa; P Propping; S Mansour; C Pollitt; T M DeChiara; R B Kimble; D M Valenzuela; G D Yancopoulos; A O Wilkie
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

7.  Metacarpophalangeal pattern profile analysis in Robinow syndrome.

Authors:  M G Butler; D D Gale; F J Meaney; W B Wadlington; M Robinow
Journal:  Am J Med Genet       Date:  1987-05

8.  Metacarpophalangeal length in the evaluation of skeletal malformation.

Authors:  S M Garn; K P Hertzog; A K Poznanski; J M Nagy
Journal:  Radiology       Date:  1972-11       Impact factor: 11.105

9.  Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients.

Authors:  R Shimkets; M R Gailani; V M Siu; T Yang-Feng; C L Pressman; S Levanat; A Goldstein; M Dean; A E Bale
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

10.  Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

Authors:  H Hahn; C Wicking; P G Zaphiropoulous; M R Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; I Smyth; C Pressman; D J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; G Chenevix-Trench; B Wainwright; A E Bale
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

  10 in total
  6 in total

1.  [Calcification of the falx cerebri. A pathognomonic symptom of Gorlin-Goltz syndrome].

Authors:  J T Lambrecht; S Stübinger; B Siewert; F Härle
Journal:  HNO       Date:  2005-08       Impact factor: 1.284

2.  9q22 Deletion--first familial case.

Authors:  Linda Siggberg; Maarit Peippo; Marjatta Sipponen; Taina Miikkulainen; Keiko Shimojima; Toshiyuki Yamamoto; Jaakko Ignatius; Sakari Knuutila
Journal:  Orphanet J Rare Dis       Date:  2011-06-22       Impact factor: 4.123

3.  High-density oligonucleotide array with sub-kilobase resolution reveals breakpoint information of submicroscopic deletions in nevoid basal cell carcinoma syndrome.

Authors:  Katsunori Fujii; Shumpei Ishikawa; Hideki Uchikawa; Daisuke Komura; Michael H Shapero; Fan Shen; Jing Hung; Hiroshi Arai; Yoko Tanaka; Kimio Sasaki; Yoichi Kohno; Masao Yamada; Keith W Jones; Hiroyuki Aburatani; Toshiyuki Miyashita
Journal:  Hum Genet       Date:  2007-08-17       Impact factor: 4.132

Review 4.  Novel microdeletion syndromes detected by chromosome microarrays.

Authors:  Anne M Slavotinek
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

5.  Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features.

Authors:  C Shaw-Smith; R Redon; L Rickman; M Rio; L Willatt; H Fiegler; H Firth; D Sanlaville; R Winter; L Colleaux; M Bobrow; N P Carter
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

6.  PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study.

Authors:  N Soufir; B Gerard; M Portela; A Brice; M Liboutet; P Saiag; V Descamps; D Kerob; P Wolkenstein; I Gorin; C Lebbe; N Dupin; B Crickx; N Basset-Seguin; B Grandchamp
Journal:  Br J Cancer       Date:  2006-08-21       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.